With €460m invested, Rinn Network's real test starts now

Introduction

Opening the doors to an enhanced national research network on the same day Ireland assumes the Presidency of the Council of the European Union is a strong signal of intent. 

The Rinn Network of seven national research centres is backed by €460 million in exchequer funding with a further €500 million to be leveraged from industry and other sources. It has the potential to play a central role in Ireland’s response to the structural commercialisation gap highlighted in the 2024 Draghi report. 

The EU has consistently failed to meet its own R&D target of 3% of GDP, something Mario Draghi identified as a fundamental reason why the EU lags the US and China. The problem is delivery as much as scale: too little of that investment turns into competitive businesses and marketable products.

Rinn is designed to address both of those issues by funding research and translating it into commercial outcomes. Research Ireland's 2026-2030 strategy sets a target of 50 active spin-out companies and 150 government awards across its funded portfolio, with the Rinn centres expected to be the primary delivery vehicle. 

The ambition is clear. What deserves equal attention is what investment at this scale demands. The governance architecture, the talent strategy, the collaboration model, the commercialisation pathways, and the evaluation frameworks established in the first six months will shape the trajectory for the eight years that follow.   

Closing the commercialisation gap 

Europe's commercialisation challenge is well documented. The Joint Research Centre's 2025 analysis confirmed that EU firms struggle more than their global counterparts to convert R&D into new ideas and marketable products. 

Ireland is not immune. Delivering Research Ireland’s target of 50 active spin-out companies will require a step-change in how research is translated into commercial outcomes. 

This requires more than good science. It needs deliberate design of the pathways between discovery and commercialisation: how IP is owned and licensed, how Technology Transfer Offices work with founders, how Enterprise Ireland's Commercialisation Fund connects to centre outputs, and how researchers are supported to think commercially without losing scientific rigour. 

This is where the design of commercialisation support becomes critical. Ireland already has meaningful infrastructure, including Enterprise Ireland's Commercialisation Fund, the I-Corps entrepreneurship training programme and university-based TTOs. 

Rinn's ambition is materially different, and the question is not whether supports are available, but whether they are integrated and scaled enough to meet the ambition now being set. 

Organisations that embed structured mentoring into their operating model from day one will be best placed to convert research strength into commercial outcomes. The strongest centres will treat commercialisation as a core function, not a parallel activity

For companies that intend to invest in research at one or more Rinn centres, clarity on how these pathways operate is vital. Simplified engagement models, transparent IP frameworks, and clearly defined routes from collaboration to commercial outcome will play a significant role in determining the level and pace of industry participation. 

Collaboration in practice 

The Rinn Network will support 577 researchers and develop over 800 PhD students across seven centres. In a global market where talent in AI, quantum computing, semiconductors, and biopharma is fiercely contested, Ireland will need to position Rinn as a compelling destination for world-class researchers. 

Attracting world-class researchers to Ireland requires competitive remuneration and clarity on career pathways, and a well-defined balance between research freedom and commercial outcomes. Retaining them requires a working environment where researchers feel supported, where there is genuine investment in professional development and where the culture values both scientific excellence and real-world impact. 

These are not secondary implementation issues; they are core design choices for the operating model that need to be made now and will determine the calibre of people the centres can attract. 

Success also requires 17 research-performing organisations to work together in a coordinated national effort of unprecedented scale. This makes collaboration one of the defining delivery challenges for Rinn. Each centre involves between three and seven research-performing organisations. They include established universities, newly formed Technological Universities, specialist institutes like Tyndall and NIBRT, the ESRI, and Queen's University Belfast. 

They have different governance structures, HR policies, IT systems and cultures. Some have long histories of collaboration, others do not. 

Early Inter-Institutional Agreements will be critical to establishing how the centres operate in practice, including IP ownership, cost-sharing, researcher mobility, data governance, publication rights and dispute resolution. 

For a centre like Rinn AI, that means DCU, TCD, UCC, UCD, Galway, ESRI, and several Technological Universities all need to reach agreement on these terms. That makes the mobilisation period a critical test of coordination. 

This is a complex exercise in institutional design. How do you create a shared governance model that respects institutional autonomy while delivering collective accountability? How do you build a culture of collaboration between organisations that may also be competing for students, staff, and funding? How do you ensure that a Technological University partner has a genuine voice alongside a larger, better-resourced traditional university? 

The answers require deliberate facilitation, experienced governance design, and a willingness from all parties to prioritise the network over individual institutional interests. 

They also require programme management discipline. Seven centres, 17 institutions, 90-day and 180-day milestones, six-monthly reporting cycles, two-yearly reviews: this is a complex programme portfolio, not a collection of independent research grants. 

Programmes of this complexity will require dedicated programme management capability from the outset: clear workstreams, defined milestones, risk registers, dependency mapping and a single view of progress across the network. 
With that discipline in place, each centre can contribute to a coherent network-level ambition rather than operating in isolation. 

Governance by design

Research Ireland has been specific about what it expects. A four-committee governance structure is a funding requirement for each centre: 

• An Executive Committee, led by the Centre Director and Co-PIs, handles operational strategy, funding allocation, cost-share compliance, and reporting. 
• A Governance Committee, convened by the President or Provost of the host institution, provides independent oversight. At least half its members must be external. The Chair must be independent and agreed with Research Ireland, who can also nominate an additional member. It meets at least twice a year and signs off on all submissions. 
• A Scientific Advisory Committee of international researchers meets annually to assess research direction. 
• An Industry Advisory Committee of senior figures from partner companies advises on commercial relevance, trends, and IP strategy. 

Governance committees alone do not deliver programmes. What we see in large-scale, multi-institutional initiatives is that the gap between governance oversight and operational delivery is where delivery momentum is either protected or lost.

Each centre will require a clearly defined operating model, setting out how decisions are made day-to-day, how resources are allocated across partner institutions, how conflicts are escalated and resolved, and how the centre director’s authority relates to the host institution’s existing management structures. A well-designed operating model is what turns governance from oversight into delivery. The governance architecture tells you who is accountable. The operating model tells you how the work actually gets done. 

Public money requires public confidence

€460 million is a significant commitment of public resources, subject to the same accountability architecture that governs the use of taxpayer funds in Ireland. The Infrastructure Guidelines, published in December 2023 and updated through Circular 08/2026, set out value-for-money requirements for the evaluation, planning, and management of public investment. 

They apply to all bodies in receipt of Exchequer capital funding. The requirements include strategic assessment, preliminary and final business cases, economic appraisal, risk assessment, benefits realisation planning, and formal evaluation at defined approval gates. 

Each centre must navigate these requirements individually, across complex multi-institutional partnerships involving up to seven organisations. Across programmes of this scale, compliance alone is not enough. Public confidence in a €460 million investment requires transparency in how funds are allocated, how they are spent, what they deliver, and where they fall short. 

In our experience, programmes that build transparent reporting into their design from the outset – including publishing how funding flows across institutions, how industry co-funding is tracked and how commercial outcomes are measured – are the ones that sustain public and political confidence over an eight-year horizon.  

When designed well, these structures do not slow delivery. They provide clarity and confidence to all parties involved, particularly where public and private investment is combined. 

Each centre must submit six-monthly progress reports to Research Ireland, approved by the Governance Committee and countersigned by the host institution's President. 

Research Ireland then conducts two-yearly performance reviews covering scientific output, commercial impact, governance quality, and financial management. These reviews carry real consequences, as Research Ireland has the authority to reduce or terminate funding for centres that fall short. 

The further €500 million to be leveraged from industry and other sources adds an important partnership dimension. It is tracked through SESAME, Research Ireland's cost-share management system. Each centre must meet defined industry co-funding targets, tracked on an ongoing basis through SESAME with specific thresholds for multinational and SME contributions. 

This creates a dual accountability: centres must satisfy both their public funder and private partners whose commercial priorities and IP assumptions than academic research. 

The tracking of industry co-funding should be accompanied by a level of public transparency that matches the scale of the public commitment. Where public and private funds are blended across 17 institutions, clarity on how each euro is allocated and accounted for is not a bureaucratic requirement but a condition of public trust. 

The signal has been sent. Whether it becomes real depends on what gets built in the next six months: the agreements between institutions, the operating models behind the governance committees, the pathways from lab to market. 

If those foundations are strong, Rinn can become the mechanism that helps narrow Ireland’s commercialisation gap and strengthens its position in the European research and innovation landscape.